Pretransplant Consolidation Therapies Improve the Outcome of Myeloablative Allogeneic Transplantation in Adults with Ph-negative Acute Lymphoblastic Leukemia-Reference-Cited by-同舟云学术

Pretransplant Consolidation Therapies Improve the Outcome of Myeloablative Allogeneic Transplantation in Adults with Ph-negative Acute Lymphoblastic Leukemia

Published:2022-08 Issue:8 Volume:22 Page:596-600
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Ozdemir Zehra Narli^ORCID,Kircali Ekin,Şahin Uğur,Seval Guldane Cengiz,Bozdağ Sinem Civriz,Toprak Selami Kocak,Yuksel Meltem Kurt,Topcuoglu Pervin,Arslan Onder,Demirer Taner,Ilhan Osman,Beksac Meral,Gurman Gunhan,Ozcan Muhit

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference15 articles.

1. Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children’s oncology group;Hunger;J Clin Oncol,2012

2. Improved survival in adult patients with acute lymphoblastic leukemia in the Netherlands: a population-based study on treatment, trial participation and survival;Dinmohamed;Leukemia,2016

3. Overall survival among older US adults with ALL remains low despite modest improvement since 1980: SEER analysis;Geyer;Blood,,2017

4. In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993)

5. Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial;Thomas;J Clin Oncol,2004